Cargando…

Is Sex a Determinant of COVID-19 Infection? Truth or Myth?

PURPOSE OF REVIEW: Angiotensin-converting enzyme 2 (ACE2), a specific high-affinity angiotensin II-hydrolytic enzyme, is the vector that facilitates cellular entry of SARS-CoV-1 and the novel SARS-CoV-2 coronavirus. SARS-CoV-2, which crossed species barriers to infect humans, is highly contagious an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Groban, Leanne, Wang, Hao, Sun, Xuming, Ahmad, Sarfaraz, Ferrario, Carlos M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2020
Materias:	Hypertension and the Heart (B Upadhya, Section Editor)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449867/ https://www.ncbi.nlm.nih.gov/pubmed/32852624 http://dx.doi.org/10.1007/s11906-020-01073-x

Ejemplares similares

Endothelial Dysfunction in COVID-19: Lessons Learned from Coronaviruses
por: Gavriilaki, Eleni, et al.
Publicado: (2020)

Mechanisms by which angiotensin-receptor blockers increase ACE2 levels
por: Ferrario, Carlos M., et al.
Publicado: (2020)

Use of machine-learning algorithms to determine features of systolic blood pressure variability that predict poor outcomes in hypertensive patients
por: Lacson, Ronilda C, et al.
Publicado: (2018)

Sex and gender differences in axial spondyloarthritis: myths and truths
por: Rusman, Tamara, et al.
Publicado: (2020)

The combination of amlodipine/valsartan 5/160 mg produces less peripheral oedema than amlodipine 10 mg in hypertensive patients not adequately controlled with amlodipine 5 mg
por: Schrader, J, et al.
Publicado: (2009)

Endothelial Dysfunction in Diabetes: The role of reparatory mechanisms
por: Avogaro, Angelo, et al.
Publicado: (2011)

Endothelial Factors and Diabetic Nephropathy
por: Karalliedde, Janaka, et al.
Publicado: (2011)

Benefits of Tight Blood Pressure Control in Diabetic Patients With Hypertension: Importance of early and sustained implementation of effective treatment strategies
por: Parati, Gianfranco, et al.
Publicado: (2011)

Antihypertensive Treatment and Blood Pressure in Diabetic and Nondiabetic Patients: The lower, the better?
por: Mancia, Giuseppe, et al.
Publicado: (2011)

Blood Pressure: The Lower, the Better: The con side
por: Grossman, Ehud
Publicado: (2011)

Diuretic Treatment of Hypertension
por: Grossman, Ehud, et al.
Publicado: (2011)

RAS Blockade for Every Diabetic Patient: Pro and Con
por: Ruilope, Luis M., et al.
Publicado: (2011)

Monitoring Kidney Function and Albuminuria in Patients With Diabetes
por: Lambers Heerspink, Hiddo J., et al.
Publicado: (2011)

Limitations and Future Treatment Options in Type 2 Diabetes With Renal Impairment
por: Ritz, Eberhard
Publicado: (2011)

Individualization of Antihypertensive Drug Treatment
por: Mancia, Giuseppe, et al.
Publicado: (2013)

Intolerance to Statins: Mechanisms and Management
por: Bitzur, Rafael, et al.
Publicado: (2013)

Prognostic Value of Blood Pressure Variability and Average Blood Pressure Levels in Patients With Hypertension and Diabetes
por: Parati, Gianfranco, et al.
Publicado: (2013)

Ambulatory Blood Pressure Monitoring in the Diagnosis and Management of Hypertension
por: Grossman, Ehud
Publicado: (2013)

Familial history of hypertension as a predictor of increased arterial stiffness in normotensive offspring
por: Youssef, Ghada, et al.
Publicado: (2017)

The Role of Nocturnal Blood Pressure and Sleep Quality in Hypertension Management
por: Cappuccio, Francesco P
Publicado: (2020)

The chaos of hypertension guidelines for chronic kidney disease patients
por: Castillo-Rodriguez, Esmeralda, et al.
Publicado: (2019)

(Pro)renin Receptor and Blood Pressure Regulation: A Focus on the Central Nervous System
por: Souza, Lucas A.C., et al.
Publicado: (2022)

Most Recent Trials and Advances in Hypertension
por: Rey-Rañal, Elías Martínez, et al.
Publicado: (2022)

Hypertension : physiopathology and treatment /
Publicado: (1977)

Novel Immune Mechanisms in Hypertension and Cardiovascular Risk
por: Nosalski, Ryszard, et al.
Publicado: (2017)

Sex Differences in the Prevalence, Outcomes and Management of Hypertension
por: Connelly, Paul J., et al.
Publicado: (2022)

Atrial angiotensin-(1-12)/chymase expression data in patient of heart diseases
por: Wang, Hao, et al.
Publicado: (2020)

Pancreatic cancer and depression: myth and truth
por: Mayr, Martina, et al.
Publicado: (2010)

COVID-19 Reinfection: Myth or Truth?
por: Roy, Sayak
Publicado: (2020)

Truths and Myths in Pediatric Migraine and Nutrition
por: Papetti, Laura, et al.
Publicado: (2021)

Earwig Crawling in the Ear: Myth or Truth
por: Jeong, Hamin, et al.
Publicado: (2021)

Inflammatory and mitochondrial gene expression data in GPER-deficient cardiomyocytes from male and female mice
por: Wang, Hao, et al.
Publicado: (2016)

Estrogen receptors are linked to angiotensin-converting enzyme 2 (ACE2), ADAM metallopeptidase domain 17 (ADAM-17), and transmembrane protease serine 2 (TMPRSS2) expression in the human atrium: insights into COVID-19
por: Wang, Hao, et al.
Publicado: (2021)

Blunting of cardioprotective actions of estrogen in female rodent heart linked to altered expression of cardiac tissue chymase and ACE2
por: da Silva, Jaqueline S., et al.
Publicado: (2017)

Megalin: a Novel Determinant of Renin-Angiotensin System Activity in the Kidney?
por: Sun, Yuan, et al.
Publicado: (2020)

Standard cystectomy fits all: truth or myth?
por: Roth, Beat, et al.
Publicado: (2015)

Moisture insensitive primer: A myth or truth
por: Shukla, Chandresh, et al.
Publicado: (2014)

Isolated pulmonary valve endocarditis: truth or myth?
por: Seraj, Siamak M., et al.
Publicado: (2017)

Schistosomiasis and Bladder Cancer in Egypt: Truths and Myths
por: Amin, Hebat Allah Ahmed, et al.
Publicado: (2019)

Understanding Type 2 Diabetes:: Truth or Myth
por: Marcinek, Leann, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8s5qdtblgo6356g8lqvbjbbpco